Meanwhile, the changes of the median proteinuria had a decreasing trend, as the median proteinuria levels at baseline and after 3 and 6 months of dapagliflozin treatment were 851.63 (547.02, 1403.21) mg/g, 640.30 (300.80, 1029.35) mg/g, and 307.92 (164.75, 616.31) mg/g, respectively.
← all excerpts
Dapagliflozin reduces proteinuria in IgA nephropathy patients receiving immunosuppressive therapy.
1
—
—